Abbott Laboratories $20 billion notes offering
We advised the joint book-running managers on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Oculis Holding $100 million at-the-market offering
We advised the sales agent on the offering
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
AbbVie $8 billion senior notes offering
We advised the representatives of the underwriters on the offering
Alignment Healthcare $256 million secondary offering
We advised the underwriter on the offering
One Call acquisition of Data Dimensions
We are advising One Call on the transaction
Tandem Diabetes Care $300 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
Revolution Medicines $1 billion at-the-market offering
We advised the sales agent on the offering
Recursion Pharmaceuticals $300 million at-the-market offering
We advised the sales agent on the offering
Amgen $4 billion notes offering
We advised the bookrunners on the offering